5 Key Takeaways

• 1

  The transition to electronic batch records is necessary to manage millions of pages of documents for producing products for 1000 patients annually.

• 2

  Automation in quality control testing can enhance the 'failure by exception' process, improving efficiency in the disposition process.

• 3

  Industry collaboration on standardizing labels and audit approaches can lead to improved utilities for patients and hospital providers.

• 4

  The cell and gene therapy industry is expected to evolve differently from monoclonals due to its multimodal nature and unique technical challenges.

• 5

  Open source code in cell and gene therapy publications can facilitate collaboration and innovation among industry professionals.